Michael Gelband’s Outset Medical OM Stock Holding History

Michael Gelband’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,605	Closed	-$39.3K	–	1947
2025 Q4	$39.3K	Hold	10,605	–	–	﹤0.01%	1460
2025 Q3	$150K	Buy	+10,605	New	+$165K	﹤0.01%	1411
2024 Q1	–	Sell	-4,901	Closed	-$398K	–	1838
2023 Q4	$398K	Buy	4,901 +2,497	+104%	+$203K	﹤0.01%	1098
2023 Q3	$392K	Sell	2,404 -2,244	-48%	-$530K	﹤0.01%	1324
2023 Q2	$1.52M	Buy	4,648 +3,424	+280%	+$1.04M	0.01%	921
2023 Q1	$338K	Buy	+1,224	New	+$449K	﹤0.01%	1444
2022 Q3	–	Sell	-840	Closed	-$187K	–	2180
2022 Q2	$187K	Buy	+840	New	+$361K	﹤0.01%	1668
2020 Q4	–	Sell	-1,886	Closed	-$1.42M	–	2269
2020 Q3	$1.42M	Buy	+1,886	New	+$1.55M	0.03%	532

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Michael Gelband's OM Position: Q1 2026 in Review

Michael Gelband sold out of Outset Medical (OM) in Q1 2026, closing a stake of 10,605 shares — an estimated $39.3K sold.

Michael Gelband first reported a position in OM in Q3 2020 and held it in 8 quarters. The position peaked at $1.52M in Q2 2023. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

Michael Gelband reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
Michael Gelband sold 10,605 Outset Medical shares in Q1 2026, an estimated $39.3K.
Michael Gelband first reported a position in Outset Medical in Q3 2020 and held it in 8 quarters.
Michael Gelband's Outset Medical position peaked at $1.52M in Q2 2023.
99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.